CELANESE
222 West Las Colinas Boulevard
Suite 900N
Irving, TX 75039
E: healthcare@celanese.com
W: vitaldose.com

CUSTOMIZED SUPPORT FOR SUSTAINED RELEASE DRUG DELIVERY THERAPIES

Celanese works closely with you as a strategic partner to create innovative controlled-release dosage forms for biologics, small molecules, and RNA to meet the goals of patient-centric therapies, improved medicine and better healthcare economics.

From FEASIBILITY to DEVELOPMENT to COMMERCIALIZATION

Our scientists and engineers are there from concept to commercialization, providing development services, material supply aligned with GMP principles and regulatory support through the Celanese Development & Feasibility Lab. Our objective is to help our customers reduce R&D time and improve the likelihood of successful drug commercialization.

INTRODUCING THE VITALDOSE^® PLATFORM

Our VitalDose^® Ethylene-Vinyl Acetate (EVA) copolymer drug-delivery platform is an enabling technology for drug-eluting implants and inserts. The platform is flexible and customizable to address and  tailor the release rate of your drug.

• Compatible with biologics, RNA, and small molecules
• Provides reliable local or systemic drug administration
• High drug loading capacity (≤ 75%)
• Achieves drug release over >6 months
• Ease of formulation and configurable into a variety of geometries
• An established regulatory path with long clinical use history

VitalDose^® EVA has been approved for use in numerous pharmaceutical and medical device applications. We are actively supporting marketed products and development programs in:

• Ophthalmic inserts & intraocular implants
• Oncology
• Women’s health
• Central nervous system disorders
• Rare diseases
• Endocrinology

ABOUT CELANESE

Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We are committed to sustainability by responsibly managing the materials we create for their entire lifecycle and are growing our portfolio of sustainable products to meet increasing customer and societal demand. We strive to make a positive impact in our communities and foster inclusivity across our teams. Celanese is a Fortune 500 company that employs approximately 12,400 employees worldwide with 2023 net sales of $10.9 billion.